CIK 0000883107 · Non-accelerated filer<br>Smaller reporting company
SOLESENCE, INC.
Sign in to watch- Ticker
- SLSN
- Exchange
- Nasdaq
- Industry
- Perfumes, Cosmetics & Other Toilet Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 363687863
- Phone
- 6307716078
- Business address
- 1319 MARQUETTE DRIVE, ROMEOVILLE, IL, 60446
- Former names
- NANOPHASE TECHNOLOGIES Corp, NANOPHASE TECHNOLOGIES CORPORATION
- 4 Open-market buy Director bought 7,100 shares at $1.50 ($10,650)
- 4 Conversion 10% owner acquired 15,000,000 shares (conversion)
- 4 Open-market buy Chief Operating Officer bought 11,675 shares at an average $1.49 ($17,414)
- 4 Open-market buy Director bought 18,369 shares at an average $1.44 ($26,487)
- 4 Open-market buy Director bought 20,787 shares at an average $1.58 ($32,900)
- 4 Open-market buy Director bought 19,040 shares at an average $1.36 ($25,962)
- 4 Open-market buy Director bought 8,837 shares at an average $1.46 ($12,871)
- 4 Open-market buy Director bought 8,563 shares at an average $1.34 ($11,490)
- 4 Open-market buy Director bought 5,300 shares at $1.40 ($7,420)
- 4 Option exercise Chief Operating Officer acquired 50,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 182,433 shares at $0.40 ($72,973)
- 4 Open-market buy President, CEO bought 7,008 shares at $0.40 ($2,803)
- 4 Open-market buy 10% owner bought 3,824,864 shares at $0.40 ($1,529,946)
- 4 Option exercise Chief Operating Officer acquired 25,000 shares (option exercise)
- 4 Option exercise President, CEO acquired 67,450 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 35 · 682 filings